# Stop Transmission of Gambiense Human African Trypanosomiasis (STROgHAT)

> **NCT06356974** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Drugs for Neglected Diseases** · enrollment: 2500 (estimated)

## Conditions studied

- Human African Trypanosomiasis

## Interventions

- **DRUG:** Treatment of seropositive individuals (positive serology test, but parasitology not confirmed)

## Key facts

- **NCT ID:** NCT06356974
- **Lead sponsor:** Drugs for Neglected Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-04-08
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2024-04-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06356974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06356974, "Stop Transmission of Gambiense Human African Trypanosomiasis (STROgHAT)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06356974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*